Published 11 August 2021 at 19.51
Domestic. The government has decided to enter into a pre-emptive agreement on vaccine doses with the manufacturer Novavax. In total, there are up to 2.2 million doses that, subject to approval, are expected to be delivered mainly during 2022–2023.
Like the article p & aring; Facebook
This is a so-called protein vaccine which, according to the government, will be a complement to the mRNA vaccines that are now most common in vaccination against covid-19 in Sweden.
Protein vaccine uses a technology other than mRNA vaccine and is said to be suitable for certain people.
“The agreement with Novavax is in line with the strategy that Sweden has with a broad portfolio of vaccines against covid-19. The purpose of buying more vaccine is to spread the risks and take into account different scenarios regarding the development of the pandemic “, the government writes in a press release.